World Neurosurgery
Volume 73, Issue 1 , Pages 42-49 , January 2010

N-acetylcysteine prevents vasospasm after subarachnoid hemorrhage

  • Onder Güney, MD

      Affiliations

    • Department of Selcuk University Meram Faculty of Medicine, Konya 42080, Turkey
    • Corresponding Author InformationCorresponding author. Department of Neurosurgery, Selcuk University Meram Faculty of Medicine, Akyokus/Meram/Konya/Turkey 42080. Tel: +90 332 2236150; fax: +90 332 2236181.
    • ,
  • Fatih Erdi, MD

      Affiliations

    • Department of Selcuk University Meram Faculty of Medicine, Konya 42080, Turkey
    • ,
  • Hasan Esen, MD

      Affiliations

    • Department of Pathology, Selcuk University Meram Faculty of Medicine, Konya 42080, Turkey
    • ,
  • Aysel Kiyici, MD

      Affiliations

    • Department of Biochemistry, Selcuk University Meram Faculty of Medicine, Konya 42080, Turkey
    • ,
  • Yalcin Kocaogullar, MD

      Affiliations

    • Department of Selcuk University Meram Faculty of Medicine, Konya 42080, Turkey

Received 6 May 2009 ,Accepted 4 June 2009.

References 

  1. Aoki K, Zubkov AY, Ross IB, et al. Therapeutic effect of caspase inhibitors in the prevention of apoptosis and reversal of chronic cerebral vasospasm. J Clin Neurosci. 2002;9:672–677
  2. Aruoma OI, Halliwell B, Hoey BM, et al. The antioxidant effect of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593–597
  3. Ayaz M, Guney O, Erdi F, et al. Electrophysiology of papillary muscle in SAH: changes and N-acetylcysteine protection. J Interv Card Electrophysiol. 2009;[Electronic publication ahead of print]
  4. Aydin MV, Caner H, Sen O, et al. Effect of melatonin on cerebral vasospasm following experimental subarachnoid hemorrhage. Neurol Res. 2005;27:77–82
  5. Ayer RE, Zhang JH. Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl. 2008;104:33–41
  6. Belen D, Besalti O, Yiğitkanli K, et al. Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage. Acta Neurochir (Wien). 2007;149:1041–1047
  7. Borel CO, McKee A, Parra A, et al. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke. 2003;34:427–433
  8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
  9. Cahill J, Calvert JW, Solaroglu I, et al. Vasospasm and p53-induced apoptosis in an experimental model of subarachnoid hemorrhage. Stroke. 2006;37:1868–1874
  10. Cakir O, Erdem K, Oruc A, et al. Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury. Cardiovasc Surg. 2003;11:375–379
  11. Cavallini L, Alexandre A. Oral N-acetylcysteine increases the production of anti-HIV chemokines in peripheral blood mononuclear cells. Life Sci. 2000;67:147–154
  12. Cook DA, Vollrath B. Free radicals and intracellular events associated with cerebrovascular spasm. Cardiovasc Res. 1995;30:493–500
  13. D'Agostini F, Izzotti A, Balansky RM, et al. Modulation of apoptosis by cancer chemopreventive agents. Mutat Res. 2005;591:173–186
  14. Demir S, Inal-Erden M. Pentoxifylline and N-acetylcysteine in hepatic ischemia/reperfusion injury. Clin Chim Acta. 1998;275:127–135
  15. Devadas S, Hinshaw JA, Zaritskaya L, et al. Fasstimulated generation of reactive oxygen species or exogenous oxidative stress sensitize cells to Fas-mediated apoptosis. Free Radic Biol Med. 2003;35:648–661
  16. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53:123–133
  17. Everse J, Hsia N. The toxicities of native and modified hemoglobins. Free Radic Biol Med. 1997;22:1075–1099
  18. Farr SA, Poon HF, Dogrukol-Ak D, et al. The antioxidants alphalipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003;84:1173–1183
  19. Fassbender K, Hodapp B, Rossol S, et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 2001;70:534–537
  20. Findlay JM, Weir BK, Kanamaru K, et al. Arterial wall changes in cerebral vasospasm. Neurosurgery. 1989;25:736–745
  21. Halliwell B, Gutteridge JM. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys. 1986;246:501–514
  22. Hicdonmez T, Kanter M, Tiryaki M, et al. Neuroprotective effects of N-acetylcysteine on experimental closed head trauma in rats. Neurochem Res. 2006;31:473–481
  23. Karaoglan A, Akdemir O, Barut S, et al. The effects of resveratrol on vasospasm after experimental subarachnoidal hemorrhage in rats. Surg Neurol. 2008;70:337–343
  24. Kassell NF, Shaffrey M, Shaffrey C. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. In:  Apuzzo M editors. Brain surgery. 1st ed.. New York: Churchill-Livingstone; 1993;p. 847–856
  25. Khan M, Sekhon B, Jatana M, et al. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res. 2004;76:519–527
  26. Kolias AG, Sen J, Belli A. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. J Neurosci Res. 2009;87:1–11
  27. Konarkowska B, Aitken JF, Kistler J, Zhang S, Cooper GJ. Thiol reducing compounds prevent human amylin-evoked cytotoxicity. FEBS J. 2005;272:4949–4959
  28. Macdonald RL, Weir BK. Cerebral vasospasm and free radicals. Free Radic Biol Med. 1994;16:633–643
  29. Nagata K, Sasaki T, Mori T, et al. Cisternal talc injection in dog can induce delayed and prolonged arterial constriction resembling cerebral vasospasm morphologically and pharmacologically. Surg Neurol. 1996;45:442–447
  30. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358
  31. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–169
  32. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther. 2005;105:23–56
  33. Sadowska AM, Manuel-y-Keenoy B, De Backer BA. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther. 2007;20:9–22
  34. San-Miguel B, Alvarez M, Culebras JM, et al. N-acetyl-cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure. Apoptosis. 2006;11:1945–1957
  35. Seckin H, Yigitkanli K, Besalti O, et al. Lamotrigine attenuates cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Surg Neurol. 2008;70:344–351
  36. Sen O, Caner H, Aydin MV, et al. The effect of mexiletine on the level of lipid peroxidation and apoptosis of endothelium following experimental subarachnoid hemorrhage. Neurol Res. 2006;28:859–863
  37. Vorkapic P, Bevan JA, Bevan RD. Two indices of functional damage of the artery wall parallel the time course of irreversible narrowing in experimental vasospasm in the rabbit. Blood Vessels. 1991;28:179–182
  38. Zachwieja J, Zaniew M, Bobkowski W, et al. Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis. Pediatr Nephrol. 2005;20:725–731
  39. Zubkov AY, Ogihara K, Bernanke DH, et al. Apoptosis of endothelial cells in vessels affected by cerebral vasospasm. Surg Neurol. 2000;53:260–266

☆ A report of this study has been presented as oral presentation at 23rd. Annual Scientific Congress of Turkish Neurosurgical Society, Girne, Cyprus, 17-21 April 2009.

PII: S0090-3019(09)00509-6

doi: 10.1016/j.surneu.2009.06.003

World Neurosurgery
Volume 73, Issue 1 , Pages 42-49 , January 2010

Article Tools

* Image Usage & Resolution